Jefferies Group LLC Dynavax Technologies Corp Put Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	BUY	$7.45 - $12.83 $93,125 - $160,375	12,500 Added 125.0%	22,500 $283,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $93,125 - $160,375	12,500 Added 125.0%	22,500 $283,000
Q2 2021 Aug 20, 2021	SELL	$7.25 - $10.99 $7.18 Million - $10.9 Million	-990,000 Reduced 99.0%	10,000 $99,000
Q2 2021 Aug 16, 2021	BUY	$7.25 - $10.99 $7.18 Million - $10.9 Million	990,000 Added 9900.0%	1,000,000 $99,000
Q1 2021 Sep 21, 2023	SELL	$4.57 - $11.18 $57,125 - $139,750	-12,500 Reduced 55.56%	10,000 $98,000
Q1 2021 May 14, 2021	BUY	$4.57 - $11.18 $45,700 - $111,800	10,000 New	10,000 $98,000
Q3 2020 Nov 13, 2020	SELL	$4.32 - $11.7 $216,000 - $585,000	-50,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.46 - $6.93 $173,000 - $346,500	50,000 New	50,000 $286,000
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $293,000 - $398,000	-20,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $304,000 - $430,000	20,000	20,000 $430,000

259

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.41B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.